Correlation Engine 2.0
Clear Search sequence regions


  • CDKN1A (6)
  • cell (2)
  • cell cycle (1)
  • cell death (1)
  • cell human (1)
  • cellular (2)
  • CIP1 (1)
  • dna repair (3)
  • eIF2α (8)
  • facilitates (1)
  • GCN2 (1)
  • human (5)
  • mrna splice (2)
  • regulates (1)
  • Sizes of these terms reflect their relevance to your search.

    In response to sublethal UVB irradiation, human keratinocytes transiently block progression of the cell cycle to allow ample time for DNA repair and cell fate determination. These cellular activities are important for evading the initiation of carcinogenesis in skin. Central to these processes is the repression of initiation of mRNA translation through GCN2 phosphorylation of eIF2α (eIF2α-P). Concurrent with reduced global protein synthesis, eIF2α-P and the accompanying Integrated stress response (ISR) selectively enhance translation of mRNAs involved in stress adaptation. In this study, we elucidated a mechanism for eIF2α-P cytoprotection in response to UVB in human keratinocytes. Loss of eIF2α-P induced by UVB diminished G1 arrest, DNA repair, and cellular senescence coincident with enhanced cell death in human keratinocytes. Genome-wide analysis of translation revealed that the mechanism for these critical adaptive responses by eIF2α-P involved induced expression of CDKN1A encoding the p21 (CIP1/WAF1) protein. We further show that human CDKN1A mRNA splice variant 4 is preferentially translated following stress-induced eIF2α-P by a mechanism mediated in part by upstream ORFs situated in the 5'-leader of CDKN1A mRNA. We conclude that eIF2α-P is cytoprotective in response to UVB by a mechanism featuring translation of a specific splice variant of CDKN1A that facilitates G1 arrest and subsequent DNA repair. © 2017 by The American Society for Cell Biology.

    Citation

    Ann E Collier, Dan F Spandau, Ronald C Wek. Translational control of a human CDKN1A mRNA splice variant regulates the fate of UVB-irradiated human keratinocytes. Molecular biology of the cell. 2017 Nov 08


    PMID: 29118075

    View Full Text